Crowdonomics
WatchlistPortfolio
All companies
Aevumed Inc. logo

Aevumed Inc.

Operating

Healthcare · Malvern, PA

Visit website
Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$5,069,000
Crowd $0 · Private $5.1M · 5 rounds since 2013
Latest share price
$9.00
Reg CF Offering (2025) offering price

Financials

FY2023–FY2024 · from SEC filings · hover any figure for its source
$606K
−$1.8M
2023
$683K
−$1.8M
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2023 reviewed
FY2024 reviewed
Income statement
Revenue
$605,657
$683,020
Cost of goods sold
-$194,413
-$178,848
Gross margin
68%
74%
Net income
-$1,790,186
-$1,757,187
Taxes paid
$0
$0
Balance sheet
Cash
$163,679
$63,645
Accounts receivable
$130,660
$15,789
Total assets
$837,021
$625,853
Short-term debt
$186,226
$497,844
Long-term debt
$886,276
$688,001
Total liabilities
$1,072,502
$1,185,845
Other
Headcount
—
9

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Fundraising history

Reg CF · Common Stock · Sep 2025Closedvia DealMaker
Raised $0 / $1.2M
Rule 506(b) · Equity · Dec 2021Closed
Raised $3MInvestors 36
Rule 506(b) · Equity · Sep 2020Closed
Raised $1.5MInvestors 21
Rule 506(b) · Equity · Apr 2018Closed
Raised $264KInvestors 10
Rule 506(b) · Debt · Nov 2013Closed
Raised $305KInvestors 10

Team

4 people
/s/ Saif Khalil, PhD
CEO
/s/ David Farmer
Director
/s/ Gerald Williams, Jr., MD
Director
/s/ William Shopoff
Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

36 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form CSep 8, 20250001096906-25-001493
    EDGAR
  • Form DJun 12, 20250002065988-25-000004
    EDGAR
  • Form DJun 12, 20250002065988-25-000002
    EDGAR
  • Form DJun 12, 20250002065988-25-000003
    EDGAR
  • Form DJun 12, 20250002065988-25-000001
    EDGAR
Source: SEC EDGARCIK 0002065988DEShare price $9.00Last synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.